USP47 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, we find that P22077, a USP47 inhibitor38, substantially eliminates TKI-sensitive cells, TKI-resistant cells, leukemia stem/progenitor cells, and MRD in CML.